Literature DB >> 18796264

Status of immune mediators in painful neuropathies.

Nurcan Uçeyler1, Claudia Sommer.   

Abstract

Peripheral neuropathies of identical etiology can be painful or painless. The reason for this difference in clinical presentation is as yet unknown; however, immune mediators, particularly cytokines, may play a role. Cytokines are proteins that are produced by immune and nonimmune cells and are categorized as pro- and anti-inflammatory. The role of cytokines in the induction and maintenance of pain has been well established in animal models. Proinflammatory cytokines are mostly algesic, whereas anti-inflammatory cytokines have analgesic properties. Clinical research also gives evidence for the involvement of cytokines in painful and painless neuropathies. A proinflammatory cytokine profile seems to be associated with pain in peripheral neuropathies of different etiologies and in other painful disorders such as the complex regional pain syndrome. Specifically, an imbalance between pro- and anti-inflammatory cytokines may contribute to pain generation. A better understanding of the underlying pathophysiology may open new opportunities for the treatment of pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796264     DOI: 10.1007/s11916-008-0029-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  42 in total

1.  Successful treatment of CRPS 1 with anti-TNF.

Authors:  Frank J P M Huygen; Sjoerd Niehof; Freek J Zijlstra; P Martin van Hagen; Paul L A van Daele
Journal:  J Pain Symptom Manage       Date:  2004-02       Impact factor: 3.612

2.  Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy.

Authors:  Oliver C Singer; Bettina Otto; Helmuth Steinmetz; Ulf Ziemann
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

3.  Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS.

Authors:  Guillermo M Alexander; M A van Rijn; J J van Hilten; Marielle J Perreault; Robert J Schwartzman
Journal:  Pain       Date:  2005-08       Impact factor: 6.961

4.  Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain.

Authors:  Nurcan Uçeyler; Regine Valenza; Michael Stock; Robert Schedel; Günter Sprotte; Claudia Sommer
Journal:  Arthritis Rheum       Date:  2006-08

5.  Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy.

Authors:  S Misawa; S Kuwabara; M Mori; N Kawaguchi; Y Yoshiyama; T Hattori
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

6.  Fibromyalgia and interleukin-2 therapy for malignancy.

Authors:  D J Wallace; K Margolin; P Waller
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

7.  Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10.

Authors:  Erin D Milligan; Stephen J Langer; Evan M Sloane; Lin He; Julie Wieseler-Frank; Kevin O'Connor; David Martin; John R Forsayeth; Steven F Maier; Kirk Johnson; Raymond A Chavez; Leslie A Leinwand; Linda R Watkins
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

8.  Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.

Authors:  C Richez; P Blanco; A Lagueny; T Schaeverbeke; J Dehais
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

9.  Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients.

Authors:  Rosane M B Teles; Sérgio L G Antunes; Márcia R Jardim; Ariane L Oliveira; José A C Nery; Ana M Sales; Elizabeth P Sampaio; Veronica Shubayev; Euzenir N Sarno
Journal:  J Peripher Nerv Syst       Date:  2007-09       Impact factor: 3.494

10.  Regional cerebral blood flow and cytokines in young females with fibromyalgia.

Authors:  A Gur; M Karakoc; S Erdogan; K Nas; R Cevik; A J Sarac
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

View more
  6 in total

1.  Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies.

Authors:  Nurcan Üçeyler; Nadja Riediger; Waldemar Kafke; Claudia Sommer
Journal:  J Neurol       Date:  2014-11-05       Impact factor: 4.849

2.  High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy.

Authors:  Thomas Eko Purwata
Journal:  J Pain Res       Date:  2011-06-29       Impact factor: 3.133

3.  Neural acupuncture unit: a new concept for interpreting effects and mechanisms of acupuncture.

Authors:  Zhang-Jin Zhang; Xiao-Min Wang; Grainne M McAlonan
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

4.  Risk Factors for Suicidal Ideation among Patients with Complex Regional Pain Syndrome.

Authors:  Do-Hyeong Lee; Eun Chung Noh; Yong Chul Kim; Jae Yeon Hwang; Sung Nyun Kim; Joon Hwan Jang; Min Soo Byun; Do-Hyung Kang
Journal:  Psychiatry Investig       Date:  2013-10-16       Impact factor: 2.505

5.  Cognitive-behavioral therapy for patients with chronic pain: Implications of gender differences in empathy.

Authors:  Jae-A Lim; Soo-Hee Choi; Won Joon Lee; Joon Hwan Jang; Jee Youn Moon; Yong Chul Kim; Do-Hyung Kang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  TNF-α mediated upregulation of NaV1.7 currents in rat dorsal root ganglion neurons is independent of CRMP2 SUMOylation.

Authors:  Flávio Henrique Pequeno de Macedo; Rosária Dias Aires; Esdras Guedes Fonseca; Renata Cristina Mendes Ferreira; Daniel Portela Dias Machado; Lina Chen; Fang-Xiong Zhang; Ivana A Souza; Virgínia Soares Lemos; Thiago Roberto Lima Romero; Aubin Moutal; Rajesh Khanna; Gerald W Zamponi; Jader S Cruz
Journal:  Mol Brain       Date:  2019-12-30       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.